N-Nitroso Edoxaban Impurity 4
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs .N-Nitroso Edoxaban Impurity 4 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 4 chemically represented as 2-bromo-5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridine . Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 4 .We supply N-Nitroso Edoxaban Impurity 4 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-E39321 |
| CAS No | NA |
| Mol.F. | C11H16N3O4 |
| Mol.Wt. | 254.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39322 |
| CAS No | 88-20-0 |
| Mol.F. | C7H8O3S |
| Mol.Wt. | 172.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39323 |
| CAS No | 2759920-22-2 |
| Mol.F. | C25H33N5O4S |
| Mol.Wt. | 499.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39324 |
| CAS No | NA |
| Mol.F. | C24H30ClN7O4S |
| Mol.Wt. | 548.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39325 |
| CAS No | NA |
| Mol.F. | C24H30ClN7O4S |
| Mol.Wt. | 548.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39326 |
| CAS No | NA |
| Mol.F. | C24H30ClN7O4S |
| Mol.Wt. | 548.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39327 |
| CAS No | 2752546-54-4 |
| Mol.F. | C9H8Cl2N2O3 |
| Mol.Wt. | 263.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39328 |
| CAS No | 365998-34-1 |
| Mol.F. | C20H28N2O6 |
| Mol.Wt. | 392.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39329 |
| CAS No | 4755-77-5 |
| Mol.F. | C4H5ClO3 |
| Mol.Wt. | 136.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39330 |
| CAS No | 143150-92-9 |
| Mol.F. | C7H9BrN2S |
| Mol.Wt. | 233.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39331 |
| CAS No | NA |
| Mol.F. | C10H17N3O2 |
| Mol.Wt. | 211.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39332 |
| CAS No | NA |
| Mol.F. | C13H25N3O3 |
| Mol.Wt. | 271.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39333 |
| CAS No | NA |
| Mol.F. | C12H22N2O4 |
| Mol.Wt. | 258.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39334 |
| CAS No | NA |
| Mol.F. | C21H30ClN5O5 |
| Mol.Wt. | 468g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39335 |
| CAS No | NA |
| Mol.F. | C21H30ClN5O5 |
| Mol.Wt. | 468g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39336 |
| CAS No | NA |
| Mol.F. | C21H30ClN5O5 |
| Mol.Wt. | 468g/mole |
| INV STATUS | CUSTOM SYNTHESIS |